August 28, 2012
CINCINNATI -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today provided the financial community with guidance regarding the Company’s fiscal 2013 sales and earnings estimates. Based on the Company’s business planning and budgeting activities for the fiscal year ending September 30, 2013, management expects net sales to be in the range of $190 to $195 million and [...]
Oxford Capital exit Sirigen in sale to Becton, Dickinson and Company
August 28, 2012
Venture capital backed High Sensitivity Fluorescence Business, Sirigen Group Limited, has been acquired by BD (Becton, Dickinson and Company), a leading global medical technology company for an undisclosed sum. Founded in 2004, Sirigen uses Nobel-prize winning science to produce light harvesting polymers which have a wide range of applications in research, medical diagnostics and life [...]
August 28, 2012
SAN DIEGO, -- Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, has announced that the latest release of the company's enterprise electronic laboratory notebook (ELN), Symyx Notebook by Accelrys, offers a new multidimensional scientific spreadsheet for use in planning, executing and tracking a wide range of biological experiments. In addition, [...]
FEI Launches New Helios NanoLab HP Platform for High Productivity TEM Sample Preparation
August 28, 2012
HILLSBORO, Ore., -- FEI (Nasdaq:FEIC), a leading instrumentation company providing imaging and analysis systems for research and industry, today announced new Helios NanoLab™ DualBeam™ systems for engineers that need to make vital process improvement decisions. The 450HP and 1200HP DualBeam systems include new capability that meets the critical requirements for semiconductor process development at the [...]
Smiths Detection Names Edgewood as U.S. Headquarters
August 28, 2012
Edgewood, MD, - Smiths Detection today formally confirmed its recently expanded plant in Edgewood, Md. as its new US headquarters, part of its strategy of aligning production more closely to major customers. Its long-standing Edgewood facility already plays a key role in meeting the growing demand for advanced threat detection technologies from government agencies and [...]
Bluechiip signs strategic partnership with Gentris Corporation
August 28, 2012
Bluechiip Limited [ASX: BCT] – which has developed a unique temperature sensing and tracking solution initially for cryogenic sample management in the healthcare and life science industry – today announced that it has signed a strategic partnership agreement with Gentris Corporation. The strategic partnership will be focused on expanding Gentris’ service model to include temperature [...]
Centice Corporation Announces $8 Million Series D Venture Financing
August 28, 2012
MORRISVILLE, NC - Centice Corporation, a pioneer in chemical verification and identification using Raman spectroscopy and computational sensor technology, today announced the closing of a convertible debt financing of $1M. This initial closing will be part of a Series D financing of up to $8M, which will include new investment and conversion of debt. The [...]
Steven C. Miller Named Chief Commercialization Officer at Senior Scientific Subsidiary of MHTX
August 28, 2012
ALBUQUERQUE, N.M.--Manhattan Scientifics (OTCBB: MHTX) announced today that its Senior Scientific subsidiary has named Steven C. Miller, Ph.D. to the position of Chief Commercialization Officer. Senior Scientific is developing and commercializing technology developed by Dr. Edward R. Flynn. Senior Scientifics’ nanotechnology and imaging technology can detect tumors and metastases much earlier than currently possible and [...]
Idaho Technology, Inc. Becomes BioFire Diagnostics, Inc.™
August 28, 2012
SALT LAKE CITY, - Idaho Technology, Inc., today announced it has changed the corporate name to BioFire Diagnostics, Inc. to more accurately reflect its business strategy and strong momentum in the marketplace. The Company has also re-launched its website (www.BioFireDx.com) to reveal its new branding. "We are excited to announce our new name to our [...]
Changes to the Roche Corporate Executive Committee
August 28, 2012
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Daniel O’Day, currently Chief Operating Officer (COO) of Roche Diagnostics has been appointed as COO of Roche Pharma effective September 1, 2012. He will succeed Pascal Soriot, who will leave Roche and take on new responsibilities outside the Group. Daniel O’Day will be succeeded by Roland [...]

